These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Adams M, Jasani B, Fiander A. Vaccine; 2007 Apr 20; 25(16):3007-13. PubMed ID: 17292517 [Abstract] [Full Text] [Related]
6. Human papillomavirus infection: an old disease, a new vaccine. Giles M, Garland S. Aust N Z J Obstet Gynaecol; 2006 Jun 20; 46(3):180-5. PubMed ID: 16704468 [Abstract] [Full Text] [Related]
7. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer. Ault K, Reisinger K. Int J Infect Dis; 2007 Nov 20; 11 Suppl 2():S26-8. PubMed ID: 18162242 [Abstract] [Full Text] [Related]
8. Vaccination against HPV: indications for women and the impact on the cervical screening programme. Heideman DA, Snijders PJ, Berkhof J, Verheijen RH, Helmerhorst TJ, Meijer CJ. BJOG; 2008 Jul 20; 115(8):938-46. PubMed ID: 18651878 [Abstract] [Full Text] [Related]
9. Understanding HPV disease and prevention: a guide for school nurses. Lockwood-Rayermann S, McIntyre SJ. J Sch Nurs; 2009 Aug 20; 25(4):261-9. PubMed ID: 19363106 [Abstract] [Full Text] [Related]
10. Age considerations when vaccinating against HPV. Wright TC, Huh WK, Monk BJ, Smith JS, Ault K, Herzog TJ. Gynecol Oncol; 2008 May 20; 109(2 Suppl):S40-7. PubMed ID: 18482558 [Abstract] [Full Text] [Related]
11. Prevention strategies against the human papillomavirus: the effectiveness of vaccination. Stanley M. Gynecol Oncol; 2007 Nov 20; 107(2 Suppl 1):S19-23. PubMed ID: 17938013 [Abstract] [Full Text] [Related]
12. Decreasing risk: impact of HPV vaccination on outcomes. Hymel PA. Am J Manag Care; 2006 Dec 20; 12(17 Suppl):S473-83. PubMed ID: 17203991 [Abstract] [Full Text] [Related]
13. [Vaccines against human papillomavirus (HPV); between registration and implementation]. van Rossum TG, de Melker HE, Houweling H, Voordouw AC, Meijer CJ, Helmerhorst TJ, Kretzschmar M, Berkhof J, van der Noordaa J. Ned Tijdschr Geneeskd; 2008 Apr 26; 152(17):987-92. PubMed ID: 18549172 [Abstract] [Full Text] [Related]
14. The current and future role of screening in the era of HPV vaccination. Myers E, Huh WK, Wright JD, Smith JS. Gynecol Oncol; 2008 May 26; 109(2 Suppl):S31-9. PubMed ID: 18482556 [Abstract] [Full Text] [Related]
15. Recommendations for cervical cancer prevention in Asia Pacific. Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R, Parkin DM, Qiao YL, Sankaranarayanan R, Stern PL, Tay SK, Bosch FX. Vaccine; 2008 Aug 19; 26 Suppl 12():M89-98. PubMed ID: 18945418 [Abstract] [Full Text] [Related]
16. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Jenkins D. Gynecol Oncol; 2008 Sep 19; 110(3 Suppl 1):S18-25. PubMed ID: 18653221 [Abstract] [Full Text] [Related]
17. Harnessing the power of prevention: human papillomavirus vaccines. Mayeaux EJ. Curr Opin Obstet Gynecol; 2006 Feb 19; 18 Suppl 1():s15-21. PubMed ID: 16520680 [Abstract] [Full Text] [Related]
18. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2011 Oct 14; 60(40):1382-4. PubMed ID: 21993342 [Abstract] [Full Text] [Related]